» Articles » PMID: 30627579

Reduced Left Ventricular Ejection Fraction Is a Risk Factor for In-Hospital Mortality in Patients After Percutaneous Coronary Intervention: A Hospital-Based Survey

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2019 Jan 11
PMID 30627579
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To evaluate whether a reduced left ventricular ejection fraction (LVEF) is a risk factor in patients after percutaneous coronary intervention (PCI).

Methods: A retrospective cohort study from February 2013 to January 2017 was performed, and 1600 patients were included (136 patients with EF <50% and 1464 patients with EF ≥50%); all patients underwent PCI. Revascularization, in-hospital mortality, and in-hospital myocardial infarction (MI) during hospitalization were evaluated.

Results: The mean age of patients with EF <50% was 62.18 ± 10.31 years, while the mean age of patients with EF ≥50% was 60.06 ± 10.89 years (P=0.029). In-hospital mortality of patients with EF ≥50% was significantly lower than that of patients with EF <50% (0.12% vs. 3.68%, P<0.001), while no difference was observed in revascularization and in-hospital MI between the two groups (2.39% vs. 2.20%, P=0.892; 0.415% vs. 1.47%, P=0.093, respectively). In the univariate analysis, no significant difference was found in revascularization and in-hospital MI between the two groups (OR: 1.50, 95% CI: 0.95 to 2.38; OR: 0.28, 95% CI: 0.06 to 1.38, respectively) except for in-hospital mortality (OR: 1.12, 95% CI: 1.05 to 1.27). In multivariate analyses, in-hospital mortality of patients with EF ≥50% was still significantly lower than of patients with EF <50% (OR: 1.15, 95% CI: 1.08 to 1.33). There were no differences in revascularization and in-hospital MI between the two groups (OR: 0.85, 95% CI: 0.44 to 1.63; OR: 0.04, 95% CI: 0.00 to 1.84, respectively).

Conclusions: Reduced LVEF is a risk factor for in-hospital mortality in patients after PCI.

Citing Articles

Procedural safety of rotational atherectomy and modified balloon angioplasty: insights from a German national registry.

Maier A, Gissler M, Jackel M, Oettinger V, Bacmeister L, Heidenreich A Clin Res Cardiol. 2024; .

PMID: 39259363 DOI: 10.1007/s00392-024-02538-8.


Prognostic Value of Preoperative Assessment of Left Ventricular Function in Patients Undergoing Percutaneous Coronary Intervention.

Yang M, Guo F, Yang Y, Jing Z, Sun K Rev Cardiovasc Med. 2024; 24(3):80.

PMID: 39077497 PMC: 11264021. DOI: 10.31083/j.rcm2403080.


Ejection Fraction-Related Differences of Baseline Characteristics and Outcomes in Troponin-Positive Patients without Obstructive Coronary Artery Disease.

Kacmaz M, Schlettert C, Kreimer F, Abumayyaleh M, Akin I, Mugge A J Clin Med. 2024; 13(10).

PMID: 38792370 PMC: 11121874. DOI: 10.3390/jcm13102826.


Optimized patient selection in high-risk protected percutaneous coronary intervention.

Leick J, Werner N, Mangner N, Panoulas V, Aurigemma C Eur Heart J Suppl. 2022; 24(Suppl J):J4-J10.

PMID: 36518889 PMC: 9730792. DOI: 10.1093/eurheartjsupp/suac060.


Clinical expert consensus document on the use of percutaneous left ventricular assist devices during complex high-risk PCI in India using a standardised algorithm.

Tayal R, Kalra S, Seth A, Chandra P, Sohal S, Punamiya K AsiaIntervention. 2022; 8(2):75-85.

PMID: 36483283 PMC: 9706744. DOI: 10.4244/AIJ-D-22-00021.


References
1.
McNeil J, Peeters A, Liew D, Lim S, Vos T . A model for predicting the future incidence of coronary heart disease within percentiles of coronary heart disease risk. J Cardiovasc Risk. 2001; 8(1):31-7. DOI: 10.1177/174182670100800105. View

2.
Daugaard G, Lassen U, Bie P, Pedersen E, Jensen K, Abildgaard U . Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction. Eur J Heart Fail. 2005; 7(1):87-93. DOI: 10.1016/j.ejheart.2004.03.009. View

3.
Alidoosti M, Salarifar M, Zeinali A, Kassaian S, Dehkordi M, Fatollahi M . Short- and long-term outcomes of percutaneous coronary intervention in patients with low, intermediate and high ejection fraction. Cardiovasc J Afr. 2008; 19(1):17-21. PMC: 3977078. View

4.
Moran A, Zhao D, Gu D, Coxson P, Chen C, Cheng J . The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China. BMC Public Health. 2008; 8:394. PMC: 2631484. DOI: 10.1186/1471-2458-8-394. View

5.
Popescu I, Werner R, Vaughan-Sarrazin M, Cram P . Characteristics and outcomes of America's lowest-performing hospitals: an analysis of acute myocardial infarction hospital care in the United States. Circ Cardiovasc Qual Outcomes. 2009; 2(3):221-7. PMC: 5361404. DOI: 10.1161/CIRCOUTCOMES.108.813790. View